-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Helus Pharma, Raises Price Target to $95

Benzinga·03/02/2026 14:04:44
Listen to the news
HC Wainwright & Co. analyst Patrick R. Trucchio maintains Helus Pharma (NASDAQ:HELP) with a Buy and raises the price target from $55 to $95.